
About the Session
As healthcare and life sciences companies digitize at scale, the pressure to protect sensitive health data and defend innovation through intellectual property has intensified. From cross-border clinical trials and AI diagnostics to global patent filings and health data regulations, legal, compliance, and R&D leaders face unprecedented privacy and IP challenges.
This global roundtable brings together privacy officers, IP counsel, regulatory experts, and healthtech innovators to explore:
-
Global privacy regulations in clinical, research, and patient-facing environments
-
Strategies to protect and enforce IP in pharma, biotech, and medtech innovation
-
AI in diagnostics and data governance implications
-
Cross-border data transfers, consents, and anonymization standards
All GC360 members will receive post-event access to the full session recording and practical toolkit via GC360Flix.


Agenda Program
Date: November 12, 2025
Healthcare & Life Sciences: Privacy & IP
12:00 – 12:10 PM GMT | Welcome & Introductions
-
Moderator’s session kickoff and objectives
-
Speaker intros: “What privacy or IP risk are you navigating right now?”
-
Live poll: “Which area is most challenging — data, IP, or both?”
12:10 – 12:40 PM GMT | Challenge 1: Privacy & Data Compliance in Clinical & Digital Health
-
Cross-border patient data, trials, and research privacy risks
-
Health-specific frameworks: HIPAA, GDPR, and national health laws
-
AI-based diagnostics, wearable devices, and secondary use of data
What You'll Gain:
Privacy risk map and cross-jurisdictional health data governance practices
12:40 – 1:10 PM GMT | Challenge 2: IP Protection in Innovation-Driven Markets
-
Strategies to protect patents, trade secrets, and biologic assets
-
Disputes over licensing, joint IP, and research partnerships
-
Patentability of AI/ML-driven discoveries and digital therapeutics
What You'll Gain:
IP strategy frameworks for digital-first, regulated healthtech sectors
1:10 – 1:40 PM GMT | Challenge 3: Managing AI, Anonymization & Global Enforcement Risk
-
Managing identifiability and re-identification risks in datasets
-
Collaboration across legal, R&D, compliance, and IT
-
Preparing for regulator scrutiny and industry audits
What You'll Gain:
Governance models balancing innovation, privacy, and IP in health and science
1:40 – 2:00 PM GMT |
Live Q&A & Closing Reflections
-
Participant questions and speaker responses
-
Final takeaways: “One privacy or IP initiative to implement in your organization”
-
Post-event toolkit and GC360Flix access
Post-Event Toolkit Includes:
-
One Key Takeaway per Speaker (compiled by GC360
-
Executive Summary of Key Learnings
-
Select Templates or Tools (if shared)
-
Full Recording Access via GC360Flix
-
Certificate of Participation
Speakers Board

Who Should Attend?
Legal, Privacy & Compliance Officers in Pharma, Biotech, MedTech
Chief IP Counsel & Patent Strategy Leaders
R&D, Regulatory Affairs, and Clinical Trial Operations Professionals
HealthTech General Counsel & Digital Transformation Executives

Why You Should Attend?
Tackle global data and IP issues across health innovation pipelines
Benchmark with experts in privacy, AI, and biopharma IP
Receive recording, tools, and compliance insights
Join GC360 Membership for 50+ global virtual roundtables across industries

Virtual Events Gallery
Topic: CISOs in the Kingdom: Ensuring Data Privacy and Security in Line with Saudi Arabia’s Vision 2030, Saudi Arabia
Topic: Uncovering Sensitive Data: How CISOs in India Can Use Data Discovery to Mitigate Privacy Risks, India
Topic: Tackling Compliance, Cyber Risk & Supply Chain Security, UAE
Topic: Crisis Management and Litigation Preparedness, APAC

















